determin
whether
adher
materi
found
wall
paranas
sinus
common
cold
might
fibrin
clot
examin
nasal
fluid
surrog
sinu
secret
young
adult
experiment
induc
rhinoviru
cold
control
subject
presenc
fibrin
mean
concentr
standard
error
insolubl
fibrin
measur
ddimer
subject
rhinoviru
cold
increas
baselin
level
mgml
peak
mgml
p
p
day
inocul
viru
fibrin
concentr
remain
baselin
level
uninfect
control
subject
determin
whether
adher
materi
found
wall
paranas
sinus
common
cold
might
fibrin
clot
examin
nasal
fluid
surrog
sinu
secret
young
adult
experiment
induc
rhinoviru
cold
control
subject
presenc
fibrin
mean
concentr
standard
error
insolubl
fibrin
measur
ddimer
subject
rhinoviru
cold
increas
baselin
level
mgml
peak
mgml
p
p
day
inocul
viru
fibrin
concentr
remain
baselin
level
uninfect
control
subject
patient
viral
rhinosinus
ie
common
cold
adher
materi
resist
mucociliari
clearanc
often
found
wall
paranas
sinus
figur
although
materi
often
refer
mucos
thicken
presenc
air
bubbl
materi
figur
make
unlik
mucos
thicken
current
studi
undertaken
investig
composit
adher
materi
particular
interest
whether
adher
materi
plasma
fibrin
clot
result
plasma
exud
viral
infect
sampl
materi
sinu
caviti
patient
cold
avail
focu
studi
shift
evalu
whether
crosslink
fibrin
could
clot
appear
nasal
fluid
surrog
sinu
fluid
subject
rhinoviru
cold
fibrinogen
plasma
report
present
transient
nasal
fluid
subject
experiment
induc
coronaviru
cold
current
studi
report
presenc
patient
rhinoviru
cold
fibrin
clot
end
product
fibrinogen
system
fibrinogen
may
convert
solubl
fibrin
enzymat
action
solubl
fibrin
convert
insolubl
clot
crosslink
ddimer
present
studi
investig
presenc
crosslink
fibrin
function
product
fibrinogen
nasal
fluid
subject
cold
addit
examin
time
cours
plasma
exud
result
increas
albumin
fibrinogen
concentr
nasal
fluid
subject
experiment
induc
rhinoviru
cold
materi
method
nasal
wash
sampl
obtain
otherwis
healthi
young
adult
age
year
common
cold
rhinoviru
challeng
control
subject
challeng
viru
becom
infect
challeng
pool
rhinoviru
type
administ
intranas
drop
ml
administr
repeat
interv
result
total
inoculum
dose
tcid
challeng
pool
safeti
test
extran
agent
nasal
lavag
fluid
sampl
obtain
day
day
total
ml
pb
without
preserv
drop
nostril
patient
sit
neck
hyperextend
nasal
fluid
ml
expel
nose
contain
two
millilit
nasal
lavag
fluid
ad
equal
volum
viru
collect
broth
use
inocul
human
embryon
lung
fibroblast
cell
cultur
andor
cell
screwcap
tube
aliquot
ml
undilut
lavag
fluid
store
use
studi
serum
sampl
obtain
challeng
week
challeng
measur
titer
homotyp
neutral
antibodi
challeng
viru
infect
consid
present
viru
recov
nasal
lavag
specimen
andor
greater
increas
serum
titer
homotyp
neutral
antibodi
respiratori
gener
symptom
record
daili
basi
method
report
jackson
studi
particip
consid
ill
hesh
minimum
symptom
score
subject
impress
cold
rhinorrhea
day
concentr
fibrinogen
fibrinogen
degrad
product
nasal
lavag
sampl
measur
mean
latex
agglutin
rabbit
antiserum
specif
fragment
e
human
fibrinogen
diagnostica
stago
sampl
pretreat
remov
unreact
fibrinogen
wish
measur
combin
concentr
fibrinogen
fibrin
monom
fibrin
clot
lavag
fluid
detect
limit
assay
mgml
express
term
fibrinogen
equival
calcul
mean
concentr
specimen
valu
mgml
assign
valu
mgml
presenc
crosslink
fibrin
nasal
lavag
sampl
measur
latex
agglutin
monoclon
antibodi
specif
crosslink
ddimer
domain
organon
teknika
detect
limit
assay
mg
ml
express
fibrinogen
equival
calcul
mean
concentr
specimen
valu
mgml
assign
valu
mgml
albumin
concentr
nasal
lavag
fluid
measur
rocket
immunoelectrophoresi
rabbit
polyclon
antibodi
human
albumin
dakopatt
albumin
concentr
sampl
determin
comparison
standard
curv
gener
run
studi
review
approv
human
investig
committe
univers
virginia
health
system
charlottesvil
subject
provid
written
inform
consent
accord
guidelin
establish
institut
result
mean
concentr
combin
fibrinogen
fibrinogen
degrad
product
nasal
lavag
sampl
obtain
infect
ill
subject
viru
challeng
mgml
figur
day
challeng
mean
concentr
increas
mgml
test
mean
concentr
p
p
day
mgml
respect
mean
concentr
fibrinogen
fibrinogen
degrad
product
control
subject
remain
baselin
level
day
observ
mean
ddimer
concentr
nasal
lavag
specimen
obtain
infect
ill
subject
viru
challeng
mgml
figur
day
leng
risen
mgml
day
challeng
increas
peak
mgml
day
mean
concentr
control
subp
p
ject
mgml
concentr
day
challeng
vari
mgml
mg
ml
subject
strong
correl
concentr
fibrinogen
fibrinogen
degrad
product
combin
albumin
concentr
r
p
lavag
sampl
figur
p
present
studi
demonstr
fibrinogen
concentr
includ
fibrinogen
degrad
product
increas
nasal
fluid
subject
rhinoviru
cold
spite
consider
differ
molecular
size
fibrinogen
kda
albumin
kda
fibrinogen
appear
transit
nasal
epithelium
readili
albumin
cold
strong
correl
concentr
fibrinogen
albumin
also
demonstr
fibrinogen
plasma
exud
convert
insolubl
crosslink
fibrin
nasal
fluid
concentr
fibrin
express
fibrinogen
equival
approxim
half
fibrinogen
fibrin
concentr
show
tempor
pattern
fibrinogen
concentr
ill
reason
assum
crosslink
fibrin
also
present
sinus
cold
may
respons
adher
materi
observ
sinu
wall
assumpt
true
presenc
fibrin
clot
implic
treatment
strategi
enhanc
drainag
sinus
cold
medic
current
use
includ
mucoevacu
decongest
would
expect
affect
crosslink
fibrin
measur
may
necessari
reduc
andor
solubil
fibrin
secret
measur
involv
reduc
influx
plasma
protein
upper
airway
lyse
fibrin
sinu
mucosa
prophylact
oral
steroid
administr
shown
reduc
albumin
kinin
concentr
nasal
fluid
volunt
experiment
induc
rhinoviru
cold
find
suggest
reduct
plasma
exud
occur
use
topic
agent
fibrinolyt
activ
might
anoth
approach
method
deliv
fibrinolyt
drug
sinu
caviti
would
need
devis
approach
success
event
presenc
insolubl
fibrin
nasal
fluid
probabl
sinu
fluid
cold
receiv
attent
may
warrant
